- USD/IDR remains heavy inside the weekly range.
- Dengue becomes the latest worries, in addition to the coronavirus, for Indonesia.
- The Asian nation sees May-June coronavirus peak of 95,000 cases.
- China data and updates concerning Gilead’s Remdesivir become the key.
With a broad risk-on sentiment in Asia, USD/IDR seesaws near 15,530, down 1.10% on a day, amid the early Friday’s trading. The reason for the pair’s decline can be traced from the catalysts concerning the coronavirus (COVID-19) and Indonesia’s domestic fundamentals.
Progress towards finding a cure to the global pandemic, clinical trials on Gilead’s Remdesivir, changed the market’s mood just after the US session close on Thursday. The news gained additional strength after US President Donald Trump’s optimistic appearance while providing details of how the economy will resort to working after the virus-led lockdown.
The market’s risk-tone cheers the news with the US 10-year Treasury yields rising seven basis points (bps) to 0.68% while stocks in Asia also flashing gains by the press time.
While broad optimism should have helped the Indonesian rupiah (IDR), the surge in the dengue cases at home becomes an additional burden, other than the virus, for the Indonesian economy. Jakarta Post cited that the numbers of recovered patients have crossed the death toll for the first time on Thursday.
On the contrary, Reuters rely on the Indonesian public health expert’s comments while saying, “Indonesia expects the number of coronavirus cases to peak between May and June with around 95,000 infections, a government adviser said on Thursday.”
Traders are currently waiting for China’s first quarter (Q1) GDP data for fresh impulse while updates concerning the virus cure will also be the key to watch during the day.
USD/IDR chart
Not only the recent low near 15,500 but late-March bottom close to 15,440 and 50-day SMA around 15,015 can also question the pair’s further downside. Meanwhile, a 21-day SMA level of 16,120 will challenge the buyers past-15,900 immediate resistance.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD stabilizes near 1.0800 as trading action turns subdued
EUR/USD holds steady near 1.0800 on Thursday and remains on track to end the day in negative territory following upbeat macroeconomic data releases from the US. The action in financial markets turn subdued as trading volumes thin out heading into Easter holiday.
GBP/USD extends sideways grind above 1.2600
GBP/USD fluctuates in a narrow channel above 1.2600 on Thursday. The better-than-expected Initial Jobless Claims data from the US and the upward revision to the Q4 GDP growth help the USD stay resilient against its rivals and limits the pair's upside.
Gold pulls away from daily highs, holds above $2,200
Gold retreats from daily highs but holds comfortably above $2,200 in the American session on Thursday. The benchmark 10-year US Treasury bond yield stays near 4.2% after upbeat US data and makes it difficult for XAU/USD to gather further bullish momentum.
XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC
XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase.
Portfolio rebalancing and reflation trades emerge into Q2
Yesterday’s price action pointed at a possible end-of-quarter portfolio rebalancing as the session saw the laggards of the quarter like Apple and Tesla gain, and the stars like Microsoft and Nvidia retreat.